Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 13(5): e0196948, 2018.
Article in English | MEDLINE | ID: mdl-29742150

ABSTRACT

Tuberculosis (TB) in animals is a re-emerging disease with a wide range of hosts that causes large economic losses in livestock. Goats are particularly susceptible to TB and, in endemic areas, vaccination may be a valuable measure to control the disease. The main aim of this study was to evaluate the efficacy of parenteral vaccination of goats with a heat-inactivated Mycobacterium bovis (HIMB) vaccine, and compare it to M. bovis Bacille Calmette-Guérin (BCG) vaccine. Twenty-four goat kids were divided in 3 groups as following: HIMB vaccinated group (n = 8), BCG vaccinated group (n = 8) and unvaccinated group (n = 8). Afterwards, goats were experimentally challenged with Mycobacterium caprae by the endobronchial route. Antigen specific interferon-γ release assays and serology were performed after vaccination and challenge. Pathological and bacteriological parameters were evaluated after necropsy at 9 weeks post-challenge (p.c.). HIMB vaccine showed similar levels of protection to BCG in terms of volume reduction of thoracic TB lesions, presence of extra-pulmonary lesions, as well as a slight reduction of bacterial load in pulmonary lymph nodes. Moreover, HIMB vaccine did not induce interferences on the interferon-γ release assay based on reagents previously developed to differentiate infected from BCG vaccinated individuals. The results indicate that HIMB is a suitable vaccine candidate for further larger-scale trials under field conditions in goats.


Subject(s)
Mycobacterium bovis/pathogenicity , Tuberculosis/prevention & control , Vaccination/methods , Vaccines, Inactivated/administration & dosage , Animals , BCG Vaccine/administration & dosage , Goats/microbiology , Hot Temperature , Lung/drug effects , Lung/microbiology , Tuberculosis/microbiology , Tuberculosis/veterinary
2.
Vet Anaesth Analg ; 42(6): 590-6, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25800204

ABSTRACT

OBJECTIVE: To compare the sedative effects of an intramuscular (IM) low dose of medetomidine in combination with butorphanol or methadone in dogs. STUDY DESIGN: Prospective, blinded, randomized clinical trial. ANIMALS: Forty-eight healthy adult dogs that required sedation for diagnostic or surgical elective procedures. METHODS: Dogs were sedated IM with medetomidine (2.5 µg kg(-1)) and either butorphanol (0.4 mg kg(-1)) or methadone (0.4 mg kg(-1)). The degree of sedation was assessed every 10 minutes, for 30 minutes, using a numeric descriptive scale. Data on heart rate (HR), respiratory rate, capillary refill time, temperature and response to a toe pinch were recorded. The response to venous catheterization at minute 30 was also evaluated. RESULTS: Both combinations produced moderate to deep sedation with a maximal effect at 20-30 minutes without significant differences in the degree of sedation between the treatments at any studied time-point. HR decreased from minute 10 to minute 30 with both opioid combinations (p<0.05); this reduction did not differ between groups (p>0.05). No differences between groups were detected in any of the other variables. CONCLUSIONS AND CLINICAL RELEVANCE: Combinations of a low dose of medetomidine with butorphanol or methadone, respectively, provide similar degrees of sedation.


Subject(s)
Butorphanol/pharmacology , Conscious Sedation/veterinary , Hypnotics and Sedatives/pharmacology , Medetomidine/pharmacology , Methadone/pharmacology , Animals , Butorphanol/administration & dosage , Conscious Sedation/methods , Dogs , Drug Therapy, Combination/veterinary , Female , Heart Rate/drug effects , Hypnotics and Sedatives/administration & dosage , Injections, Intramuscular/veterinary , Male , Medetomidine/administration & dosage , Methadone/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...